Frankfurt - Delayed Quote EUR
GH Research PLC (1KA.F)
10.70
-0.90
(-7.76%)
At close: June 13 at 9:15:05 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1KA.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 5/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2025 |
| Initiated | Guggenheim: Buy | 3/13/2025 |
| Initiated | RBC Capital: Outperform | 3/7/2025 |
| Maintains | Stifel: Buy to Buy | 2/27/2025 |
| Initiated | Cantor Fitzgerald: Overweight | 2/13/2025 |
Related Tickers
9VC.MU ATAI Life Sciences NV
1.9300
-2.18%
9VC.DE Atai Life Sciences N.V.
1.8545
-2.83%
9VC.F Atai Life Sciences N.V.
1.7920
-1.86%
NEUP Neuphoria Therapeutics Inc.
6.82
-5.40%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
CYBN Cybin Inc.
8.35
-3.47%
ATAI Atai Life Sciences N.V.
2.1100
-3.21%
EYEN Eyenovia, Inc.
2.4400
-8.61%